abrdn Life Sciences Investors
HQL
52 hedge funds and large institutions have $61.8M invested in abrdn Life Sciences Investors in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
9% more capital invested
Capital invested by funds: $56.7M → $61.8M (+$5.06M)
8% more funds holding
Funds holding: 48 → 52 (+4)
0.53% more ownership
Funds ownership: 13.01% → 13.53% (+0.53%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$2.1M |
| 2 |
LPL Financial
San Diego,
California
|
+$1.64M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$528K |
| 4 |
NEPWA
New England Private Wealth Advisors
Wellesley,
Massachusetts
|
+$288K |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$249K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$677K |
| 2 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$550K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$406K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$398K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$383K |
HQL Hedge Fund Activity: Q4 2015 in Review
52 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2015, worth a combined $61.8M — up 8.9% from $56.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new HQL positions and 5 closed out — a net gain of 4 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Bank of Nova Scotia, opening a new position worth an estimated $2.1M. The largest seller was Citigroup, cutting an estimated $677K.
- 52 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2015, up from 48 in Q3 2015.
- Funds reported $61.8M of abrdn Life Sciences Investors stock for Q4 2015, up 8.9% quarter-over-quarter.
- 9 funds opened new abrdn Life Sciences Investors positions in Q4 2015 and 5 closed out, a net change of +4 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2015 was Bank of Nova Scotia, an estimated $2.1M added.
- The largest abrdn Life Sciences Investors seller in Q4 2015 was Citigroup, an estimated $677K sold.
Based on aggregated 13F filings for Q4 2015.